Harry Suryapranata
#150,631
Most Influential Person Now
Harry Suryapranata's AcademicInfluence.com Rankings
Harry Suryapranataengineering Degrees
Engineering
#6073
World Rank
#7373
Historical Rank
Biomedical Engineering
#505
World Rank
#515
Historical Rank
Harry Suryapranataphilosophy Degrees
Philosophy
#8309
World Rank
#11662
Historical Rank
Logic
#5346
World Rank
#6737
Historical Rank
Download Badge
Engineering Philosophy
Harry Suryapranata's Degrees
- PhD Biomedical Engineering University of California, Berkeley
- Doctorate Medicine Stanford University
Why Is Harry Suryapranata Influential?
(Suggest an Edit or Addition)Harry Suryapranata's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Time Delay to Treatment and Mortality in Primary Angioplasty for Acute Myocardial Infarction: Every Minute of Delay Counts (2004) (1450)
- Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. (1998) (1345)
- A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. (1993) (1316)
- Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. (2002) (644)
- Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. (2005) (621)
- Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. (2000) (567)
- Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. (1999) (491)
- Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. (2003) (441)
- Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial (2008) (438)
- Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II Pilot Study. (1996) (431)
- Angiographic Assessment of Reperfusion in Acute Myocardial Infarction by Myocardial Blush Grade (2003) (394)
- The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial. (2001) (329)
- Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. (1998) (315)
- Acute Coronary Artery Occlusion During and After Percutaneous Transluminal Coronary Angioplasty: Frequency, Prediction, Clinical Course, Management, and Follow‐up (1991) (312)
- Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial (2019) (288)
- Prognostic Assessment of Patients With Acute Myocardial Infarction Treated With Primary Angioplasty: Implications for Early Discharge (2004) (284)
- Reperfusion therapy in elderly patients with acute myocardial infarction: a randomized comparison of primary angioplasty and thrombolytic therapy. (2002) (279)
- Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial. (2003) (271)
- Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials. (2012) (245)
- Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty. (2004) (234)
- Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis (2013) (231)
- The effect of completeness of revascularization on event-free survival at one year in the ARTS trial. (2002) (229)
- Folate therapy and in-stent restenosis after coronary stenting. (2004) (212)
- Long-term recovery of left ventricular function after primary angioplasty for acute myocardial infarction. (2001) (197)
- Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial. (2004) (190)
- Limitation of Infarct Size and Preservation of Left Ventricular Function After Primary Coronary Angioplast Compared With Intravenous Streptokinase in Acute Myocardial Infarction (1994) (188)
- Immediate coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: left ventricular ejection fraction, hospital mortality and reinfarction. (1994) (160)
- Randomized Comparison of the Nobori Biolimus A9-Eluting Coronary Stent With the Taxus Liberté Paclitaxel-Eluting Coronary Stent in Patients With Stenosis in Native Coronary Arteries: The NOBORI 1 Trial—Phase 2 (2009) (158)
- Adjunctive mechanical devices to prevent distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction: a meta-analysis of randomized trials. (2007) (157)
- Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplasty. (2004) (153)
- Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. (2004) (152)
- A meta-analytic overview of thrombectomy during primary angioplasty. (2013) (151)
- Folate Therapy and In-Stent Restenosis after Coronary Stenting (2004) (147)
- Coronary stenting versus balloon angioplasty for acute myocardial infarction: a meta-regression analysis of randomized trials. (2008) (141)
- Randomized comparison of primary coronary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction. (1997) (138)
- Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction. (2005) (136)
- Influence of prehospital administration of aspirin and heparin on initial patency of the infarct-related artery in patients with acute ST elevation myocardial infarction. (2002) (127)
- Role of collateral circulation in the acute phase of ST-segment-elevation myocardial infarction treated with primary coronary intervention. (2004) (124)
- A comparison of two invasive strategies in patients with non-ST elevation acute coronary syndromes: results of the Early or Late Intervention in unStable Angina (ELISA) pilot study. 2b/3a upstream therapy and acute coronary syndromes. (2003) (124)
- Safety and efficacy of recombinant hirudin (CGP 39 393) versus heparin in patients with stable angina undergoing coronary angioplasty. (1993) (121)
- Is the difference in outcome between men and women treated by primary percutaneous coronary intervention age dependent? Gender difference in STEMI stratified on age (2013) (116)
- Influence of treatment delay on infarct size and clinical outcome in patients with acute myocardial infarction treated with primary angioplasty. (1998) (115)
- Impact of gender difference on vitamin D status and its relationship with the extent of coronary artery disease. (2015) (114)
- Randomised comparison of Nobori, biolimus A9-eluting coronary stent with a Taxus(R), paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial. (2007) (112)
- Unsuccessful reperfusion in patients with ST-segment elevation myocardial infarction treated by primary angioplasty. (2005) (108)
- Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction. (2004) (103)
- Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. (2009) (103)
- First-generation versus second-generation drug-eluting stents in current clinical practice: updated evidence from a comprehensive meta-analysis of randomised clinical trials comprising 31 379 patients (2014) (102)
- Ageing, impaired myocardial perfusion, and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty. (2005) (102)
- A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study. (2002) (97)
- Randomized Comparison Between Stenting and Off-Pump Bypass Surgery in Patients Referred for Angioplasty (2003) (97)
- Long-term Effects of Angiopeptin Treatment in Coronary Angioplasty Reduction of Clinical Events but Not Angiographic Restenosis (1995) (97)
- Final results of the Randomised Evaluation of short-term DUal antiplatelet therapy in patients with acute Coronary syndromE treated with a new generation stent (REDUCE) trial. (2019) (94)
- Predictors of 30-day and 1-year mortality after primary percutaneous coronary intervention for ST-elevation myocardial infarction (2009) (93)
- A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction. (1995) (93)
- Relationship between homocysteine and coronary artery disease. Results from a large prospective cohort study. (2014) (92)
- Feasibility and benefit of prehospital diagnosis, triage, and therapy by paramedics only in patients who are candidates for primary angioplasty for acute myocardial infarction. (2006) (89)
- A randomized comparison of intra-aortic balloon pumping after primary coronary angioplasty in high risk patients with acute myocardial infarction. (1999) (87)
- Impact of Diabetes on Long-Term Outcome After Primary Angioplasty (2013) (86)
- Benefits from intracoronary as compared to intravenous abciximab administration for STEMI patients undergoing primary angioplasty: a meta-analysis of 8 randomized trials. (2012) (82)
- Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial. (2014) (81)
- Predictors and clinical implications of early reinfarction after primary angioplasty for ST-segment elevation myocardial infarction. (2006) (79)
- Sex-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty: data from the Zwolle Myocardial Infarction study. (2004) (79)
- Reperfusion strategies in acute ST-elevation myocardial infarction: an overview of current status. (2008) (78)
- Outcome in patients treated with primary angioplasty for acute myocardial infarction due to left main coronary artery occlusion. (2003) (77)
- Long-term impact of multivessel disease on cause-specific mortality after ST elevation myocardial infarction treated with reperfusion therapy (2006) (75)
- High dose heparin as pretreatment for primary angioplasty in acute myocardial infarction: the Heparin in Early Patency (HEAP) randomized trial. (2000) (73)
- Impaired Myocardial Perfusion Is a Major Explanation of the Poor Outcome Observed in Patients Undergoing Primary Angioplasty for ST-Segment–Elevation Myocardial Infarction and Signs of Heart Failure (2004) (73)
- Comparison of myocardial perfusion after successful primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction with versus without diabetes mellitus. (2005) (72)
- Impact of adjunctive tirofiban administration on myocardial perfusion and mortality in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction (2005) (72)
- Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention. (2014) (71)
- Transferring patients for primary angioplasty: a retrospective analysis of 104 selected high risk patients with acute myocardial infarction (1997) (69)
- Primary percutaneous coronary intervention versus thrombolytic treatment: long term follow up according to infarct location (2005) (68)
- Stenting of venous bypass grafts: A new treatment modality for patients who are poor candidates for reintervention (1992) (68)
- Abstract 1996: Non-culprit Lesions Detected During Primary PCI: Treat Invasively Or Follow The Guidelines? (2007) (67)
- Is routine stenting for acute myocardial infarction superior to balloon angioplasty? A randomised comparison in a large cohort of unselected patients (2005) (65)
- Effect of coronary occlusion site on angiographic and clinical outcome in acute myocardial infarction patients treated with early coronary intervention. (2006) (64)
- Comprehensive meta-analysis of radial vs femoral approach in primary angioplasty for STEMI. (2013) (64)
- Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease. (2015) (64)
- Clinical results after coronary stenting with the Genous™ Bio-engineered R stent™: 12-month outcomes of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry. (2011) (63)
- Time course, predictors and clinical implications of stent thrombosis following primary angioplasty (2013) (62)
- Randomised comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction (1998) (62)
- Multicenter evaluation of the phosphorylcholinecoated biodivYsio stent in short de novo coronary lesions: The SOPHOS study (2000) (58)
- Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials. (2006) (57)
- Impact of sex on uric acid levels and its relationship with the extent of coronary artery disease: A single-centre study. (2015) (57)
- Neutrophil to Lymphocyte Ratio and the Extent of Coronary Artery Disease (2016) (57)
- Meta-analysis of randomized trials of glycoprotein IIb/IIIa inhibitors in high-risk acute coronary syndromes patients undergoing invasive strategy. (2011) (56)
- Non-culprit lesions detected during primary PCI: treat invasively or follow the guidelines? (2007) (56)
- One year clinical follow-up of the XIENCE V Everolimus-eluting stent system in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II study. (2007) (56)
- Angiographic findings and catheterization laboratory events in patients with primary coronary angioplasty or streptokinase therapy for acute myocardial infarction. (1995) (53)
- Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction. (2008) (53)
- Prognostic significance of residual cumulative ST-segment deviation after mechanical reperfusion in patients with ST-segment elevation myocardial infarction. (2005) (53)
- Long-term, cause-specific mortality after myocardial infarction in diabetes. (2004) (53)
- Advanced age and high‐residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor (2016) (52)
- A comparison of dual vs. triple antiplatelet therapy in patients with non-ST-segment elevation acute coronary syndrome: results of the ELISA-2 trial. (2005) (52)
- Circadian variation in myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty. (2005) (52)
- Coronary angioplasty in patients with unstable angina pectoris: is there a role for thrombolysis? (1988) (51)
- Long term outcome and cost-effectiveness of stenting versus balloon angioplasty for acute myocardial infarction (2001) (51)
- Abciximab as Adjunctive Therapy to Reperfusion in Acute ST-Segment Elevation Myocardial Infarction: A Meta-analysis of Randomized Trials (2005) (49)
- Mortality in patients with left ventricular ejection fraction </=30% after primary percutaneous coronary intervention for ST-elevation myocardial infarction. (2007) (48)
- Comparison of usefulness of C-reactive protein versus white blood cell count to predict outcome after primary percutaneous coronary intervention for ST elevation myocardial infarction. (2008) (47)
- Circumflex artery-related acute myocardial infarction: limited ECG abnormalities but poor outcome (2007) (44)
- 1-Year Results of the REMEDEE Registry: Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered (Combo) Stent in a Multicenter, Prospective All-Comers Registry. (2016) (44)
- Everolimus eluting stent vs first generation drug-eluting stent in primary angioplasty: A pooled patient-level meta-analysis of randomized trials. (2017) (43)
- Mortality, reinfarction, left ventricular ejection fraction and costs following reperfusion therapies for acute myocardial infarction. (1996) (42)
- Clinical impact of simultaneous complete revascularization vs. culprit only primary angioplasty in patients with st-elevation myocardial infarction and multivessel disease: a meta-analysis (2011) (41)
- Complete revascularisation in ST-elevation myocardial infarction and multivessel disease: meta-analysis of randomised controlled trials (2015) (40)
- Aspirin desensitization in patients undergoing planned or urgent coronary stent implantation. A single-center experience. (2013) (38)
- Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial. (2014) (38)
- Incidence and predictors of subacute thrombosis in patients undergoing primary angioplasty for an acute myocardial infarction (2006) (37)
- PlA1/PlA2 polymorphism does not influence response to Gp IIb-IIIa inhibitors in patients undergoing coronary angioplasty (2013) (35)
- Clinical outcomes of deferred revascularisation using fractional flow reserve in patients with and without diabetes mellitus (2016) (35)
- Clinical presentation and outcome of patients with early, intermediate and late reperfusion therapy by primary coronary angioplasty for acute myocardial infarction. (1998) (35)
- Incidence, predictors and prognostic importance of bleeding after primary PCI for ST-elevation myocardial infarction. (2010) (35)
- Meta-analysis of 14 trials comparing bypass grafting vs drug-eluting stents in diabetic patients with multivessel coronary artery disease. (2014) (34)
- Statins and Risk of New-Onset Diabetes Mellitus: is there a Rationale for Individualized Statin Therapy? (2013) (34)
- Comparative predictive value of infarct location, peak CK, and ejection fraction after primary PCI for ST elevation myocardial infarction (2009) (34)
- Uric acid levels and the risk of Contrast Induced Nephropathy in patients undergoing coronary angiography or PCI. (2015) (33)
- It’s a small world after all (2012) (32)
- Relation of interhospital delay and mortality in patients with ST-segment elevation myocardial infarction transferred for primary coronary angioplasty. (2005) (31)
- Usefulness of repeat coronary angiography 24 hours after successful balloon angioplasty to evaluate early luminal deterioration and facilitate quantitative analysis. (1993) (31)
- Combined optical coherence tomography morphologic and fractional flow reserve hemodynamic assessment of non- culprit lesions to better predict adverse event outcomes in diabetes mellitus patients: COMBINE (OCT–FFR) prospective study. Rationale and design (2016) (30)
- Impact of age on long-term outcome after primary angioplasty with bare-metal or drug-eluting stent (from the DESERT cooperation). (2013) (30)
- Old Age and Outcome After Primary Angioplasty for Acute Myocardial Infarction (2010) (29)
- Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation. (2016) (29)
- Coronary vasodilatory action after a single dose of nicorandil. (1988) (28)
- Impact of diabetes on immature platelets fraction and its relationship with platelet reactivity in patients receiving dual antiplatelet therapy (2016) (28)
- Short and long-term safety and efficacy of polymer-free vs. durable polymer drug-eluting stents. A comprehensive meta-analysis of randomized trials including 6178 patients. (2014) (28)
- Vitamin D levels and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor (2016) (28)
- Effects of HDL-modifiers on cardiovascular outcomes: a meta-analysis of randomized trials. (2015) (27)
- Contrast volume to creatinine clearance ratio for the prediction of contrast-induced nephropathy in patients undergoing coronary angiography or percutaneous intervention (2016) (27)
- Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease. (2016) (27)
- Nicorandil and Cardiovascular Performance in Patients with Coronary Artery Disease (1992) (26)
- Impact of age on mean platelet volume and its relationship with coronary artery disease: A single-centre cohort study (2015) (26)
- Ventricular fibrillation in acute myocardial infarction before and during primary PCI. (2005) (26)
- Prehospital triage in the ambulance reduces infarct size and improves clinical outcome. (2011) (26)
- Meta-analysis comparing efficacy and safety of first generation drug-eluting stents to bare-metal stents in patients with diabetes mellitus undergoing primary percutaneous coronary intervention. (2013) (26)
- Postprocedural single-lead ST-segment deviation and long-term mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty (2007) (25)
- Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future (2015) (25)
- Primary coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: differences in outcome during a mean follow‐up of 18 months (1994) (25)
- Closure device or manual compression in patients undergoing percutaneous coronary intervention: a randomized comparison. (2010) (25)
- Impact of infarct location on left ventricular ejection fraction after correction for enzymatic infarct size in acute myocardial infarction treated with primary coronary intervention. (2006) (25)
- Atrial fibrillation after but not before primary angioplasty for ST-segment elevation myocardial infarction of prognostic importance (2012) (25)
- Optimal Duration of Dual Antiplatelet Therapy After DES Implantation (2016) (25)
- Prognostic importance of troponin T and creatine kinase after elective angioplasty. (2007) (25)
- Prevention of distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction (2006) (24)
- Homocysteine and its effects on in-stent restenosis. (2005) (24)
- Shock Index More Sensitive Than Cardiogenic Shock in ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention. (2017) (24)
- Gender Differences in Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy (2016) (24)
- Argatroban during percutaneous transluminal coronary angioplasty: Results of a dose-verification study (1996) (24)
- Combination of electrocardiographic and angiographic markers of reperfusion in the prediction of infarct size in patients with ST-segment elevation myocardial infarction undergoing successful primary angioplasty. (2007) (23)
- Mean platelet volume and the risk of periprocedural myocardial infarction in patients undergoing coronary angioplasty. (2013) (23)
- Novel X-ray image noise reduction technology reduces patient radiation dose while maintaining image quality in coronary angiography (2015) (23)
- Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor (2015) (22)
- Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor. (2016) (22)
- Is ischemia the only factor predicting cardiovascular outcomes in all diabetes mellitus patients? (2017) (22)
- Incidence and predictors of restenosis after successful primary coronary angioplasty for acute myocardial infarction: the importance of age and procedural result. (1998) (22)
- Left main coronary artery stenosis undetected by 64-slice computed tomography: a word of caution (2007) (22)
- Predictors and outcome of grade 3 ischemia in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. (2011) (22)
- Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: rationale and design of the REDUCE trial. (2016) (21)
- Duration of dual antiplatelet therapy and outcome in patients with acute coronary syndrome undergoing percutaneous revascularization: A meta-analysis of 11 randomized trials. (2018) (21)
- Early Discharge After Primary Percutaneous Coronary Intervention: The Added Value of N‐Terminal Pro–Brain Natriuretic Peptide to the Zwolle Risk Score (2014) (21)
- One year clinical outcomes in patients with insulin-treated diabetes mellitus and non-insulin-treated diabetes mellitus compared to non-diabetics after deployment of the bio-engineered COMBO stent. (2017) (21)
- Immature platelet fraction and high-on treatment platelet reactivity with ticagrelor in patients with acute coronary syndromes (2016) (21)
- Efficacy and Safety of Stents in ST-Segment Elevation Myocardial Infarction. (2019) (21)
- Diabetes mellitus, glucose control parameters and platelet reactivity in ticagrelor treated patients. (2016) (21)
- COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction (2021) (21)
- Lanreotide reduces serum free and total insulin-like growth factor-I after angioplasty. (1996) (20)
- Recent Advances in Optimal Adjunctive Antithrombotic Therapy in STEMI Patients Undergoing Primary Angioplasty: An Overview. (2015) (20)
- Absolute eosinophils count and the extent of coronary artery disease: a single centre cohort study (2015) (20)
- Prognostic value of erythrocyte sedimentation rate in ST segment elevation myocardial infarction: interaction with hyperglycaemia (2005) (20)
- Impact of hypertension on clinical outcome in STEMI patients undergoing primary angioplasty with BMS or DES: insights from the DESERT cooperation. (2014) (20)
- ST-segment elevation resolution and outcome in patients treated with primary angioplasty and glucose-insulin-potassium infusion. (2005) (20)
- Pre-diabetes and the risk of contrast induced nephropathy in patients undergoing coronary angiography or percutaneous intervention. (2014) (20)
- Dual Versus Single Antiplatelet Regimen With or Without Anticoagulation in Transcatheter Aortic Valve Replacement: Indirect Comparison and Meta-analysis. (2017) (20)
- The influence of residential distance on time to treatment in ST-elevation myocardial infarction patients (2014) (20)
- Impact of transfer for primary percutaneous coronary intervention on survival and clinical outcomes (from the HORIZONS-AMI Trial). (2010) (19)
- Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor (2015) (19)
- Closure of a coronary fistula with a transcatheter implantable coil. (1992) (19)
- Primary angioplasty compared with thrombolysis in acute myocardial infarction in diabetic patients. (1999) (19)
- Impact of neutrophil-to-lymphocyte ratio on periprocedural myocardial infarction in patients undergoing non-urgent percutaneous coronary revascularisation (2016) (19)
- Aspiration thrombectomy and primary percutaneous coronary intervention (2006) (18)
- Limitation of myocardial infarct size after primary angioplasty: is a higher patency the only mechanism? (1999) (18)
- Impact of beta-blocker therapy at discharge on long-term mortality after primary angioplasty for ST-segment elevation myocardial infarction. (2005) (18)
- Radial vs Femoral Approach in Acute Coronary Syndromes: A Meta- Analysis of Randomized Trials. (2017) (18)
- The effect of thrombus aspiration during primary percutaneous coronary intervention on clinical outcome in daily clinical practice (2013) (18)
- Impact of ST-segment depression resolution on mortality after successful mechanical reperfusion in patients with ST-segment elevation acute myocardial infarction. (2005) (18)
- Comparison of rapamycin- and paclitaxel-eluting stents in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction. (2009) (17)
- Homocysteine Levels Influence Platelet Reactivity in Coronary Artery Disease Patients Treated With Acetylsalicylic Acid (2015) (16)
- Switching from high-dose clopidogrel to prasugrel in ACS patients undergoing PCI: a single-center experience (2014) (16)
- Stenting of venous bypass grafts: a new treatment modality for patients who are poor candidates for reintervention. (1991) (16)
- Uric acid and high-residual platelet reactivity in patients treated with clopidogrel or ticagrelor. (2016) (16)
- Bivalirudin as compared to unfractionated heparin in patients undergoing percutaneous coronary revascularization: A meta-analysis of 22 randomized trials. (2015) (16)
- Twelve-month outcomes after coronary stenting with the Genous™ bio-engineered R Stent™ in diabetic patients from the e-HEALING registry. (2011) (16)
- Cardiogenic Shock Predicts Long‐term Mortality in Hospital Survivors of STEMI Treated With Primary Percutaneous Coronary Intervention (2016) (15)
- A comparison between upfront high-dose tirofiban versus provisional use in the real-world of non-selected STEMI patients undergoing primary PCI (2010) (15)
- Long-term effects of angiopeptin treatment in coronary angioplasty. Reduction of clinical events but not angiographic restenosis. European Angiopeptin Study Group. (1995) (15)
- Fractional Flow Reserve-Guided Deferred Versus Complete Revascularization in Patients With Diabetes Mellitus. (2016) (15)
- Impact of adenosine A2a receptor polymorphism rs5751876 on platelet reactivity in ticagrelor treated patients (2018) (15)
- Gender-related differences in outcome after BMS or DES implantation in patients with ST-segment elevation myocardial infarction treated by primary angioplasty: insights from the DESERT cooperation. (2013) (15)
- Gender Difference in the Risk of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography or Percutaneous Coronary Intervention (2017) (15)
- Coronary angioplasty immediately after thrombolysis in 115 consecutive patients with acute myocardial infarction. (1988) (15)
- Coronary haemodynamics and vasodilatory profile of a potassium channel opener in patients with coronary artery disease. (1993) (15)
- Duration of dual antiplatelet therapy and outcomes after coronary stenting with the genous™ bio‐engineered R stent™ in patients from the e‐healing registry (2012) (14)
- The predictive value of cumulative lactate dehydrogenase release within the first 72 h of acute myocardial infarction in patients treated with primary angioplasty (2004) (14)
- Impact of statin therapy at discharge on 1-year mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty. (2006) (14)
- Two-year clinical outcomes of patients treated with the dual-therapy stent in a 1000 patient all-comers registry (2017) (14)
- Predictors of elevated cardiac troponin T on admission in ST-segment elevation myocardial infarction (2006) (14)
- DAPT Score and the Impact of Ticagrelor Monotherapy During the Second Year After PCI. (2020) (14)
- Evaluation of clinical outcomes after COMBO stent treatment in patients presenting with acute coronary syndrome (2017) (14)
- Distal embolic protection during percutaneous coronary intervention in patients with acute coronary syndromes: The RUBY study (2006) (14)
- Prevalence and predictors of bridging of coronary arteries in a large Indonesian population, as detected by 64-slice computed tomography scan (2012) (14)
- Clinical and quantitative angiographic outcomes following elective implantation of the self-expanding Wallstent for longer coronary artery lesions--final results of the Wellstent native study. (1999) (13)
- Primary percutaneous coronary intervention for ST-elevation myocardial infarction: from clinical trial to clinical practice. (2009) (13)
- Impact of vessel size on distal embolization, myocardial perfusion and clinical outcome in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction (2009) (13)
- Absence of seasonal variation in myocardial perfusion, enzymatic infarct size, and mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty. (2005) (13)
- Percutaneous Versus Surgical Revascularization for Left Main or Multivessel Coronary Artery Disease: Results From a Large-Scale Meta-Analysis in the Era of Drug-Eluting Stents (2018) (13)
- Comparison between stenting and balloon in elderly patients undergoing primary angioplasty for ST-segment elevation myocardial infarction. (2007) (13)
- Tirofiban for myocardial infarction (2010) (13)
- Preprocedural Thrombolysis in Myocardial Infarction (TIMI) flow significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute anterior myocardial infarction treated by primary angioplasty. (2005) (13)
- Early or late intervention in patients with transient ST‐segment elevation acute coronary syndrome: Subgroup analysis of the ELISA‐3 trial (2016) (13)
- Comparative Assessment of Predictive Performance of PRECISE-DAPT, CRUSADE, and ACUITY Scores in Risk Stratifying 30-Day Bleeding Events (2020) (12)
- Elevated Homocysteine and the Risk of Contrast-Induced Nephropathy (2015) (12)
- Impact of diabetes on the benefits from everolimus-eluting stent as compared to first-generation drug-eluting stent in patients with ST elevation myocardial infarction (2015) (12)
- Long-term results of the randomized comparison of everolimus-eluting stents and sirolimus-eluting stent in patients with ST elevation myocardial infarction (RACES-MI trial). (2016) (12)
- Clinical and angiographic results with the beStent: the Registry for Optimal beStent Evaluation (ROSE) trial (2000) (12)
- Impact of atorvastatin or rosuvastatin co-administration on platelet reactivity in patients treated with dual antiplatelet therapy. (2015) (12)
- Pre-hospital administration of tirofiban in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: a sub-analysis of the On-Time 2 trial. (2010) (12)
- The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS Trial (2020) (11)
- The impact of glucose-insulin-potassium infusion in acute myocardial infarction on infarct size and left ventricular ejection fraction [ISRCTN56720616] (2005) (11)
- Field triage in the ambulance versus referral via non-percutaneous coronary intervention centre in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: A systematic review (2017) (11)
- Ticagrelor in the prevention of coronary and non-coronary atherothrombotic events: A comprehensive meta-analysis of 10 randomized trials. (2019) (11)
- Factors associated with deferred lesion failure following fractional flow reserve assessment in patients with diabetes mellitus (2017) (11)
- Evaluation of the Safety and Cardioprotective Effects of Eniporide, a Specific Sodium/Hydrogen Exchange Inhibitor, Given as Adjunctive Therapy to Reperfusion in Patients with Acute Myocardial Infarction (2001) (11)
- The influence of system delay on 30-day and on long-term mortality in patients with anterior versus non-anterior ST-segment elevation myocardial infarction: a cohort study (2015) (11)
- Diagnosis of takotsubo cardiomyopathy is increasing over time in patients presenting as ST-elevation myocardial infarction (2016) (11)
- Impact of Long-Term Dual Antiplatelet Therapy on Immature Platelet Count and Platelet Reactivity (2018) (11)
- Pre-treatment with clopidogrel and postprocedure troponin elevation after elective percutaneous coronary intervention (2006) (11)
- Applying the National Institute for Clinical Excellence criteria to patients treated with the Genous™ Bio-engineered R stent™: a sub-study of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry (2012) (11)
- Immature platelet fraction and the extent of coronary artery disease: A single centre study. (2017) (11)
- Impact of Diabetes on Homocysteine Levels and Its Relationship with Coronary Artery Disease: A Single-Centre Cohort Study (2016) (10)
- Troponin T elevation and prognosis after multivessel compared with single-vessel elective percutaneous coronary intervention (2007) (10)
- Platelet microaggregation inhibition in patients with acute myocardial infarction pretreated with tirofiban and relationship with angiographic and clinical outcome. (2006) (10)
- Direct drug-eluting stenting to reduce stent restenosis: a randomized comparison of direct stent implantation to conventional stenting with pre-dilation or provisional stenting in elective PCI patients. (2014) (10)
- Risk and Benefits of Triple Therapy in Patients Undergoing Coronary Stent Implantation Requiring Oral Anticoagulation: A Meta-Analysis of 16 Studies (2016) (10)
- Effect of paclitaxel elution from reservoirs with bioabsorbable polymer compared to a bare metal stent for the elective percutaneous treatment of de novo coronary stenosis: the EUROSTAR-II randomised clinical trial. (2011) (10)
- Vitamin D levels and platelet reactivity in diabetic patients receiving dual antiplatelet therapy. (2019) (10)
- Coronary Stenting With the Genous(TM) Bio-Engineered R Stent(TM) in Elderly Patients (2011) (10)
- Successful reperfusion for acute ST elevation myocardial infarction is associated with a decrease in WBC count. (2006) (10)
- Suboptimal anticoagulation with pre-hospital heparin in ST-elevation myocardial infarction (2011) (10)
- Twelve-month clinical outcomes after coronary stenting with the Genous Bio-engineered R Stent in patients with a bifurcation lesion: from the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) registry (2012) (10)
- Age-dependent differences in diabetes and acute hyperglycemia between men and women with ST-elevation myocardial infarction: a cohort study (2013) (10)
- Benefits of short-term or prolonged as compared to standard 1 year DAPT in patients with acute coronary syndrome treated with drug-eluting stents: a meta-analysis of 9 randomized trials (2020) (10)
- High-Density Lipoproteins and Coronary Artery Disease (2014) (10)
- Polymer free vs polymer-coated drug-eluting stents for the treatment of coronary artery disease: A meta-analysis of 16 randomized trials. (2020) (9)
- Feasibility and Outcomes of Transcatheter Aortic Valve Implantation Using the Left Axillary Artery as Primary Access Site. (2019) (9)
- The Na+/H+exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction11This manuscript is dedicated to the memory of Karl-Ludwig Neuhaus (1944–2000). (2001) (9)
- Coronary vasodilatory action after nicorandil: a quantitative angiographic study. (1989) (9)
- External validity of ST elevation myocardial infarction trials: The Zwolle studies (2007) (9)
- The prognostic importance of heart failure and age in patients treated with primary angioplasty (2003) (9)
- Randomised comparison of drug-eluting versus bare-metal stenting in patients with non-ST elevation myocardial infarction (2016) (9)
- Prevalence and predictors of high-on treatment platelet reactivity during prasugrel treatment in patients with acute coronary syndrome undergoing stent implantation. (2019) (9)
- Are patients with non-ST elevation myocardial infarction undertreated? (2007) (9)
- Efficacy and safety of rapamycin as compared to paclitaxel-eluting stents: a meta-analysis. (2010) (9)
- Impact of routine stenting on clinical outcome in diabetic patients undergoing primary angioplasty for ST-segment elevation myocardial infarction. (2006) (9)
- Paclitaxel-eluting versus bare metal stents in primary PCI: a pooled patient-level meta-analysis of randomized trials (2014) (8)
- First‐in‐man study of a thinner‐strut sirolimus‐eluting bioresorbable scaffold (FUTURE‐I): Three‐year clinical and imaging outcomes (2020) (8)
- Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI (2014) (8)
- Impact of pre-procedural dual antiplatelet therapy on periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions with adjunctive tirofiban. (2018) (8)
- Prehospital initiation of tirofi ban in patients with ST-elevation myocardial infarction undergoing primary angioplasty ( On-TIME 2 ) : a multicentre , double-blind , randomised controlled trial (2008) (8)
- Predictors and importance of prolonged hospital stay after primary PCI for ST elevation myocardial infarction (2011) (8)
- Impact of ischemic time on post-infarction left ventricular function in ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. (2013) (8)
- Eosinophils count and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions. (2014) (8)
- Costs of stenting for acute myocardial infarction (1998) (8)
- Comparison between ticlopidine and clopidogrel in patients with ST-segment elevation myocardial infarction treated with coronary stenting (2004) (8)
- Early ambulance initiation versus in-hospital initiation of high dose clopidogrel in ST-segment elevation myocardial infarction (2014) (7)
- Bivalirudin Versus Unfractionated Heparin in Acute Coronary Syndromes: An Updated Meta-analysis of Randomized Trials. (2016) (7)
- A multi-site coronary sampling study on CRP in non-STEMI: Novel insights into the inflammatory process in acute coronary syndromes. (2018) (7)
- Switching from Clopidogrel to Prasugrel in patients undergoing PCI: A meta-analytic overview (2015) (7)
- Acetylsalicylic acid desensitization in patients with coronary artery disease: A comprehensive overview of currently available protocols. (2016) (7)
- Adjunctive abciximab to reperfusion therapy in patients with acute st-segment elevation myocardial infarction: A meta-analysis of randomized trials (2005) (7)
- PARATHYROID HORMONE LEVELS AND HIGH-RESIDUAL PLATELET REACTIVITY IN PATIENTS RECEIVING DUAL ANTIPLATELET THERAPY WITH ACETYLSALICYLIC ACID AND CLOPIDOGREL OR TICAGRELOR (2016) (7)
- Densitometrically observed differences in elastic recoil of the three main coronary arteries after percutaneous transluminal coronary angioplasty (1990) (7)
- Three‐year clinical outcomes after dual‐therapy COMBO stent placement: Insights from the REMEDEE registry (2019) (7)
- Impact of routine stenting on myocardial perfusion and the extent of myocardial necrosis in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction. (2006) (7)
- Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study. (2016) (7)
- Impact of increasing dose of intracoronary adenosine on peak hyperemia duration during fractional flow reserve assessment. (2019) (7)
- 741-1 Clinical Experience with Heparin-Coated Stents–The Benestent II Pilot Phase 1 (1995) (7)
- Impact of Age on the Functional Evaluation of Intermediate Coronary Stenoses With Instantaneous Wave-Free Ratio and Fractional Flow Reserve (2020) (7)
- Coronary vasodilatory action of elgodipine in coronary artery disease. (1992) (7)
- Prehospital triage for angiography-guided therapy for acute myocardial infarction. (2004) (6)
- Poor outcome after recurrent acute myocardial infarction: a plea for optimal secondary prevention. (2011) (6)
- Primary coronary intervention for ST-elevation myocardial infarction in Indonesia and the Netherlands: a comparison (2009) (6)
- Sirolimus-eluting versus paclitaxel-eluting stent in primary angioplasty: a pooled patient-level meta-analysis of randomized trials (2014) (6)
- Patency and Reinfarction in Late-Entry Myocardial Infarct Patients Treated with Reperfusion Therapy (1997) (6)
- Drug-eluting stents in patients with anterior STEMI undergoing primary angioplasty: a substudy of the DESERT cooperation (2014) (6)
- Impact of aging on platelet reactivity in diabetic patients receiving dual antiplatelet therapy (2019) (6)
- Angiographic predictors of left ventricular ejection fraction after successful angioplasty in acute myocardial infarction: an angiographic risk score for use in the catheterization laboratory. (2003) (6)
- Angiographic determination of myocardial reperfusion by primary coronary angioplasty for acute myocardial infarction. (2002) (6)
- Impact of immature platelet fraction on platelet reactivity during prasugrel maintenance treatment (2018) (6)
- Change of white blood cell count more prognostic important than baseline values after primary percutaneous coronary intervention for ST elevation myocardial infarction. (2008) (6)
- Facilitated reperfusion with prehospital glycoprotein IIb/IIIa inhibition: predictors of complete ST-segment resolution before primary percutaneous coronary intervention in the On-TIME 2 trial: correlates of reperfusion before primary PCI. (2011) (6)
- Platelet PIA1/PIA2 polymorphism and the risk of periprocedural myocardial infarction in patients with acute coronary syndromes undergoing coronary angioplasty (2014) (6)
- Impact of vascular access on the development of contrast induced nephropathy in patients undergoing coronary angiography and/or percutaneous coronary intervention. (2019) (6)
- Use, timing and outcome of coronary angiography in patients with high-risk non-ST-segment elevation acute coronary syndrome in daily clinical practice: insights from a ‘real world’ prospective registry (2018) (6)
- Comparison between stenting and balloon angioplasty in patients undergoing primary angioplasty of small coronary vessels. (2006) (6)
- Tako-tsubo cardiomyopathy is age-dependent in men, but not in women. (2015) (6)
- Higher neutrophil-to-lymphocyte ratio (NLR) increases the risk of suboptimal platelet inhibition and major cardiovascular ischemic events among ACS patients receiving dual antiplatelet therapy with ticagrelor. (2020) (5)
- Very short dual antiplatelet therapy after PCI and new DES: a meta-analysis of 5 randomized trials. (2020) (5)
- Platelet Larger Cell Ratio and High-on Treatment Platelet Reactivity During Dual Antiplatelet Therapy (2015) (5)
- Use of Metformin and Platelet Reactivity in Diabetic Patients Treated with Dual Antiplatelet Therapy. (2018) (5)
- Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients. (2015) (5)
- Prognostic impact of Vitamin D deficiency in patients with coronary artery disease undergoing percutaneous coronary intervention. (2020) (5)
- Coronary stenting with the Genous™ Bio-Engineered R Stent™ in elderly patients. (2011) (5)
- Association of lower vitamin D levels with inflammation and leucocytes parameters in patients with and without diabetes mellitus undergoing coronary angiography (2020) (5)
- Angiographic determinants of infarct size after successful percutaneous intervention for acute ST-elevation myocardial infarction: the impact of distal embolisation. (2002) (5)
- Benefits with drug-coated balloon as compared to a conventional revascularization strategy for the treatment of coronary and non-coronary arterial disease: a comprehensive meta-analysis of 45 randomized trials. (2021) (5)
- Multi‐Site Coronary Vein Sampling Study on Cardiac Troponin T Degradation in Non–ST‐Segment–Elevation Myocardial Infarction: Toward a More Specific Cardiac Troponin T Assay (2019) (5)
- Parathyroid Hormone Levels and High-Residual Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy With Acetylsalicylic Acid and Clopidogrel or Ticagrelor. (2016) (5)
- Routine upstream versus selective down stream use of tirofiban in non-ST elevation myocardial infarction patients scheduled for early invasive therapy; a randomized comparison (2007) (5)
- Dual Antiplatelet Therapy Duration in Acute Coronary Syndrome Patients: The State of the Art and Open Issues (2020) (5)
- Pharmacodynamics and safety of lefradafiban, an oral platelet glycoprotein IIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty (2001) (5)
- Treatment assignment in young women with spontaneous coronary artery dissection. (2014) (5)
- Abstract 6000: Clinical Outcome for the Endothelial Progenitor Cells Capturing Genous Stent: First Results of the 1-Year Follow-Up in 5000 Patients (2008) (4)
- Two-year outcome after early or late Intervention in non-ST elevation acute coronary syndrome (2017) (4)
- The extent of ST elevation and ST deviation as predictors of mortality in ST-segment elevation myocardial patients planned to undergo primary percutaneous coronary intervention. (2016) (4)
- Prognostic importance of left ventricular function after angioplasty or thrombolysis for acute myocardial infarction. (2001) (4)
- Impact of diabetes on fibrinogen levels and its relationship with platelet reactivity and coronary artery disease: A single-centre study. (2015) (4)
- Poly (l‐lactic acid) bioresorbable scaffolds versus metallic drug‐eluting stents for the treatment of coronary artery disease: A meta‐analysis of 11 randomized trials (2019) (4)
- Resting Pd/Pa and haemodynamic relevance of coronary stenosis as evaluated by fractional flow reserve (2017) (4)
- NT-proBNP during and after primary PCI for improved scheduling of early hospital discharge (2016) (4)
- Relationship between time-to-reperfusion and 30-day mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty (2003) (4)
- Stent implantation in very small coronary arteries: the Tsunami SV International Registry. (2004) (4)
- Predictors of early ventricular fibrillation before reperfusion therapy for acute ST-elevation myocardial infarction. (2004) (4)
- Histological features 3 to 320 days after stenting of human saphenous vein bypass grafts (1991) (4)
- Short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO™ dual-therapy stent: what we plan to learn from REDUCE. (2015) (3)
- Cholecalciferol levels, inflammation and leukocytes parameters: Results from a large single-centre cohort of patients. (2020) (3)
- The Zwolle global experience on primary percutaneous coronary intervention. (2005) (3)
- Circumflex artery related myocardial infarction: less reperfusion therapy and large infarct size. (2013) (3)
- Primary angioplasty for acute myocardial infarction (2004) (3)
- Possibilities and limitations of myocardial flow reserve (1994) (3)
- Argatroban during percutaneous transluminal coronary angioplasty; Results of a dose finding study. (1996) (3)
- Statin therapy and mortalitiy in patients with ST-segment elevation myocardial infarction treated with primary angioplasty. (2004) (3)
- Long-term performance of the COMBO dual-therapy stent: Results from the REMEDEE Registry. (2020) (3)
- Coronary artery bypass grafting early after acute myocardial infarction in patients initially treated with thrombolytic therapy or coronary angioplasty (1994) (3)
- Gender differences with short-term vs 12 months dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-years follow-up results of the REDUCE trial (2021) (3)
- Impact of aging on the effects of intracoronary adenosine, peak hyperemia and its duration during fractional flow reserve assessment (2021) (3)
- "PRAGUE" randomized clinical trials: pride of Czech cardiology (2009) (3)
- Gender differences in platelet reactivity in diabetic patients receiving dual antiplatelet therapy. (2020) (3)
- Cardioprotective effects of adenosine transport inhibition during reversible ischaemia in patients with coronary artery disease. (1999) (3)
- Angiographic predictors of left ventricular ejection fraction after successful angioplasty in acute myocardial infarction: An angiographic risk score for use in the catheterization laboratory (2004) (3)
- A quantitative analysis of the benefits of pre-hospital infarct angioplasty triage on outcome in patients undergoing primary angioplasty for acute myocardial infarction (2005) (3)
- Usefulness of updated logistic clinical SYNTAX score based on MI‐SYNTAX score in patients with ST‐elevation myocardial infarction (2020) (3)
- Routine stenting vs. balloon angioplasty in ST-segment elevation myocardial infarction due to proximal left anterior descending coronary artery occlusion (2009) (2)
- Folate therapy and in-stent stenosis after coronary stenting (2004) (2)
- Stenting and abciximab in primary angioplasty: a review of current status. (2005) (2)
- Relationship between adenosine A2a receptor polymorphism rs5751876 and fractional flow reserve during percutaneous coronary intervention (2020) (2)
- Two‐year safety evaluation of a biodegradable polymer sirolimus‐eluting stent with increased drug elution and polymer absorption kinetics in complex patient and lesion cohort (2020) (2)
- Impact of diabetes mellitus on immature platelet fraction and its association with coronary artery disease (2020) (2)
- Impact of age on the comparison between short-term vs 12-month dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-Year follow-up results of the REDUCE trial. (2021) (2)
- Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23-Month Ticagrelor Monotherapy in Patients Undergoing Staged Percutaneous Coronary Intervention (A Sub-Study from GLOBAL LEADERS). (2020) (2)
- Gender-related differences in outcome after BMS or DES implantation in patients with ST-segment elevation myocardial infarction treated by primary angioplasty: insights from the DESERT cooperation (2013) (2)
- Final five‐year results of the REMEDEE Registry: Real‐world experience with the dual‐therapy COMBO stent (2020) (2)
- Vitamin D deficiency and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions. (2018) (2)
- Vitamin D levels condition the outcome benefits of renin-angiotensin system inhibitors (RASI) among patients undergoing percutaneous coronary intervention. (2020) (2)
- SARS-CoV-2 Positivity, Stent Thrombosis, and 30-day Mortality in STEMI Patients Undergoing Mechanical Reperfusion. (2022) (2)
- ST-segment elevation myocardial infarction: Historical perspective and new horizons (2020) (2)
- Low hemoglobin predicts high‐platelet reactivity and major cardiovascular ischemic events at long‐term follow‐up among ACS patients receiving dual antiplatelet therapy with ticagrelor (2021) (2)
- IMPACT OF RENIN-ANGIOTENSIN SYSTEM INHIBITORS ON MORTALITY DURING THE COVID PANDEMIC AMONG DIABETIC PATIENTS WITH STEMI UNDERGOING MECHANICAL REPERFUSION: INSIGHT FROM AN INTERNATIONAL STEMI REGISTRY (2022) (1)
- The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent. (2021) (1)
- P5867COMBINE OCT and FFR assessment of non culprit lesions to better predict adverse event outcomes in diabetes mellitus patients. Rationale, design and initial OCT results (2017) (1)
- Angiography guided therapy in an all comer acute coronary syndrome patient population. (2013) (1)
- Ticagrelor and prasugrel in acute coronary syndrome: a single-arm crossover platelet reactivity study (2021) (1)
- Effects of chronic beta-blocker treatment on admission haemodynamics in STEMI patients treated with primary angioplasty (2020) (1)
- The emerging role of stenting for acute myocardial infarction. (1999) (1)
- Corrigendum to "Duration of dual antiplatelet therapy and outcome in patients with acute coronary syndrome undergoing percutaneous revascularization: A meta-analysis of 11 randomized trials" [Int. J. Cardiol. 264 (2018) 30-38]. (2018) (1)
- Coronary stenting and abciximab in primary angioplasty for ST-segment-elevation myocardial infarction. (2005) (1)
- Cardiac Troponin Composition Characterization after Non ST-Elevation Myocardial Infarction: Relation with Culprit Artery, Ischemic Time Window, and Severity of Injury. (2020) (1)
- TCT-63 One Year Results Of The REMEDEE Registry: Clinical Outcomes After Deployment Of The Abluminal Sirolimus Coated Bio-Engineerd Stent In A Multicenter, Prospective Post Market Registry (2015) (1)
- Comparison of Outcomes and Intervention Among Patients With Non-ST-Segment Elevation Acute Myocardial Infarction of Those With a Left Circumflex Versus Those With a Non-Left Circumflex-Related Coronary Artery (From the ELISA-3 Trial). (2018) (1)
- Percutaneous coronary intervention vs medical treatment in stable angina: the never-ending story. (2014) (1)
- AS10 AutoPulse facilitated resuscitation in out-of-hospital cardiac arrest as a brigde to coronary intervention (2011) (1)
- Primary angioplasty: preprocedural pharmacological therapy. (2006) (1)
- The importance of patency of the infarct-related artery in treatment of patients with acute myocardial infarction. (2003) (1)
- Long-term clinical outcome of ST-segment elevation myocardial infarction patients with and without diabetes mellitus in the Zwolle trial. (2003) (1)
- Abstract 12645: Coronary Sinus Biomarker Assessments in Non-ST Elevation Acute Coronary Syndrome: Systemic or Local Cardiac Release of High Sensitivity C-Reactive Protein? (2016) (1)
- [Identical results of primary percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction admitted as a result of direct or indirect referral]. (1999) (1)
- Clinical characteristics and outcome of patients with acute myocardial infarction and preinfarction angina. (2001) (1)
- Evaluation of the safety and cardioprotective effects of eniporide, a specific sodium/hydrogen exchange inhibitor, given as adjunctive therapy to reperfusion in patients with acute myocardial infarction: Rationale, design and protocol of the ESCAMI study (2001) (1)
- The influence of time to treatment on clinical outcome in patients with acute myocardial infarction treated with primary angioplasty (1997) (1)
- Reply to “Stenting versus plain old angioplasty in patients with ST segment elevation myocardial infarction: Understanding of the randomized trials” (2009) (1)
- Abstract of papers to be presented at the 39th Annual Scientific Session of the American College of Cardiology, New Orleans, Louisiana, March 18–22, 1990Acute complications of ptca for chronic total occlusion (1990) (1)
- Treatment of acute myocardial infarction [1] (1993) (1)
- DUAL ANTIPLATELET THERAPY VERSUS SINGLE ANTIPLATELET REGIMEN WITH OR WITHOUT ANTICOAGULATION IN TRANSCATHETER AORTIC VALVE REPLACEMENT: INDIRECT COMPARISON AND META-ANALYSIS (2017) (1)
- Coronary intervention with a heparin-coated stent and aspirin only. (2003) (1)
- Proof of principle of a novel co-pulsating intra-ventricular membrane pump. (2020) (1)
- A comparison of 2 second generation drug eluting stents (Zotarolimus versus Everolimus), in elective PCI patients (2013) (1)
- Incidence and predictors of complications during transportation of patients with acute myocardial infarction to a percutaneous coronary intervention centre : An on-time substudy (2004) (0)
- CIRCUMFLEX ARTERY RELATED MYOCARDIAL INFARCTION: LESS REPERFUSION THERAPY AND LARGE INFARCT SIZE (2012) (0)
- Troponin t elevation at baseline and failure of reperfusion after acute myocardial infarction. An on-time substudy (2004) (0)
- Catheterization and Interventional Cardiology in Adult Patients (2010) (0)
- Coronary angioplasty in patients with non-Q wave myocardial infarction (1990) (0)
- TCT-262 Clinical Outcomes of Deferred Revascularisation Using Fractional Flow Reserve in Patients With and Without Diabetes Mellitus. (2016) (0)
- randomized trial for acute myocardial infarction: The glucose-insulin-potassium study: a Glucose-insulin-potassium infusion inpatients treated with primary angioplasty (2011) (0)
- TCT-634 Randomized Comparison of Direct Stenting with Conventional and Provisional Stent Implantation in Elective PCI Patients Using Bare Metal and Drug Eluting Stents (2012) (0)
- Early fluvastatin treatment reduces the long-term incidence of major adverse cardiovascular events following successful first percutaneous coronary intervention with or without the use of stent: The lescolfi intervention prevention study (2003) (0)
- mergency Stenting for Refract During Coronary Angioplasty nar rter cclusion (0)
- Impact of Smoking Status on Mortality in STEMI Patients Undergoing Mechanical Reperfusion for STEMI: Insights from the ISACS–STEMI COVID-19 Registry (2022) (0)
- TCT-586 Long-term performance of the Dual-therapy COMBO stent: results from the REMEDEE Registry (2018) (0)
- Adjunctive thrombus aspiration versus conventional percutaneous coronary intervention in ST-elevation myocardial infarction: insights from the Zwolle Acute Myocardial Infarction registry (2013) (0)
- P954Value of a single bolus erythopoetin in STEMI patients treated with the Genous endothelial progenitor cell capture stent (2019) (0)
- CORONARY ARTERY DISEASE Twelve-month Outcomes After Coronary Stenting (2011) (0)
- Impact of the Polymorphism rs5751876 of the Purinergic Receptor ADORA2A on Periprocedural Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (2020) (0)
- AGE-RELATED EFFECTS OF COVID-19 PANDEMIC ON MECHANICAL REPERFUSION AND 30-DAY MORTALITY FOR STEMI: RESULTS OF THE ISACS-STEMI COVID-19 REGISTRY (2022) (0)
- EFFECTIVENESS OF THROMBUS ASPIRATION IN STEMI PATIENTS IN DAILY CLINICAL PRACTICE : INSIGHTS FROM THE ZWOLLE ACUTE MYOCARDIAL INFARCTION REGISTRY (2012) (0)
- Bibu 104xx: A new, oral glycoprotein lib-iiia receptor blocker, initial experience (1997) (0)
- Meta-analysis of Randomized Trials Acute ST-Segment Elevation Myocardial Infarction : A Abciximab as Adjunctive Therapy to Reperfusion in Correction (2005) (0)
- Clinical and quantitative angiographic results of a randomized trial comparing direct coronary angioplasty with intravenous streptokinase in acute myocardial infarction (1994) (0)
- Gender Difference in the Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry (2023) (0)
- TCT-77 Risk and benefits of triple therapy in patients undergoing percutaneous coronary stent implantation requiring chronic oral anticoagulation: a meta-analysis of 12 trials (2015) (0)
- PREDICTORS AND PROGNOSIS OF SPONTANEOUS CORONARY ARTERY DISSECTION IN YOUNG WOMEN PRESENTING WITH STEMI (2013) (0)
- AS-4: Routine Use of a New Endothelial Progenitor Cell Antibody-Coated Stent in Patients with Primary PCI for ST-Elevation Myocardial Infarction: A Prospective Registry (2009) (0)
- TCT-213 Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor (2015) (0)
- Long-term comparison of balloon angioplasty with provisional stenting versus routine stenting in patients with non-ST-elevation acute coronary syndrome (2010) (0)
- TCT-3 A randomized comparison of drug-eluting vs. bare metal stenting in patients with non-ST elevation myocardial infarction. Results of the ELISA-3 angiographic substudy (2014) (0)
- 1001-4 Impact of initial patency of the infarct related vessel on outcome in patients with acute myocardial infarction treated with primary angioplasty (2004) (0)
- 382 IMPACT OF AGE ON MORTALITY IN STEMI PATIENTS DURING THE SARS-COV2 PANDEMIC:DATA FROM THE ISACS-STEMI COVID-19 REGISTRY (2022) (0)
- 833-3 Statin therapy and mortality in patients with acute myocardial infarction treated with primary angioplasty (2004) (0)
- Flow and ortality in Patients With Acute yocardial Infarction Treated by Primary Angioplasty (2016) (0)
- Coronary angioplasty with monorail technique: experience in more than 2000 cases. (1993) (0)
- Bivalirudin and the Matrix Trial: The End of the Story? (2015) (0)
- P5535Gender differences with short-term vs 12 months dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: a 1-year analysis of the REDUCE trial (2019) (0)
- Are There Differences in the Demographics and Clinical Outcomes Between Asian and European Patients Treated With the COMBO Dual Therapy Stent in the REDUCE Trial Populations? (2022) (0)
- Impact of 719Trp>Arg Polymorphism of KIF 6 Gene on Contrast Induced Nephropathy in Patients Undergoing Coronary Angiography or Percutaneous Coronary Intervention (2022) (0)
- Statin therapy and mortality in patients (2008) (0)
- Tenecteplase followed by immediate angioplasty is more effective than tenecteplase alone for people with STEMI. Commentary. (2005) (0)
- Women Make the Difference in Heart Disease (2011) (0)
- PROGNOSTIC IMPACT OF AGE WITH SHORT-TERM VS. 12 MONTHS DUAL ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME: A SUB-ANALYSIS OF THE REDUCE TRIAL (2020) (0)
- Prehospital triageforangiography-gu ided therapyforacutemyocardialinfarction (2004) (0)
- Age-Related Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry (2023) (0)
- Impact of anticoagulation strategy with bivalirudin or heparin on nonaccess site bleeding in percutaneous coronary interventions: A meta‐analysis of randomized trials (2017) (0)
- UvA-DARE ( Digital Academic Repository ) Coronary Stenting With the Genous ( TM ) Bio-Engineered R Stent ( TM ) in Elderly Patients Damman (2011) (0)
- Methodological problems related to the assessment of recoil and balloon-artery ratio (1991) (0)
- Routine stenting for acute myocardial infarction: a randomized trial in unselected patients (2004) (0)
- TCT-427 Three Year Clinical Performance of the Dual-therapy COMBO stent: Insights from the REMEDEE Registry (2017) (0)
- Post heparin-coated coronary stenting with an antithrombotic regimen of aspirin only. The PHARAO study (2003) (0)
- Abstract 2564: No Late and no Very Late Stent Thrombosis with a Drug-Eluting Stent of the Second Generation: 2 Years Results from the Randomized NOBORI-I Trial (2008) (0)
- IMPACT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON SHORT-TERM OUTCOME IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION DURING COVID-19 PANDEMIC: INSIGHTS FROM THE INTERNATIONAL MULTICENTER ISACS-STEMI REGISTRY (2022) (0)
- Dual Antiplatelet Therapy for 3 or 12 Months in Patients with Non-ST-elevation MI/Unstable Angina or ST-elevation MI: Analysis of the REDUCE Trial (2022) (0)
- Abstract 18006: The Relationship Between Residual ST-segment Deviation and Biomarkers in Patients with STEMI Undergoing Primary PCI: A Sub-analysis of the On-TIME 2 Trial (2010) (0)
- TCT-627 Does direct DES stenting reduces restenosis; a randomized comparison of direct stent implantation to stenting with predilation or provisional stenting in elective PCI patients (2012) (0)
- Long-term clinical outcome of ST-segment elevation myocardial infarction patients with and without diabetes (2008) (0)
- Predictors of mortality and risk stratification in primary angioplasty Part 3 (2004) (0)
- Chapter 8 PCI for chronic stable coronary artery disease (2010) (0)
- TCT-512 Fractional Flow Reserve-Guided Deferred Versus Complete Revascularisation in Patients With Diabetes Mellitus. (2016) (0)
- Renin-angiotensin system inhibitors and mortality among diabetic patients with STEMI undergoing mechanical reperfusion during the COVID-19 pandemic (2021) (0)
- S4-3 UPDATE ON INTERVENTIONAL THERAPY FOR STEMI (2007) (0)
- Wailstent implantation as first choice for venous graft angioplasty: the Wellstent-CABG-study (1998) (0)
- Abstract 17709: Central Coronary Venous Troponin Concentrations as a Guide to the Identification of the Culprit Vessel in Multivessel Coronary Artery Disease (2011) (0)
- Chapter 6 Left ventricular angiography and other angiocardiographic techniques (2010) (0)
- P4503A multi-site coronary vein sampling study on cardiac troponin T degradation in non-ST-elevation myocardial infarction (2019) (0)
- Left Main Dissection During Primary Angioplasty for Acute Myocardial Infarction (AMI) (2004) (0)
- Final benefit of primary percutaneous coronary intervention for ST-elevation myocardial infarction in older patients: long-term results of a randomised trial (2022) (0)
- Impact of multivessel disease on recovery of left ventricular function after primary angioplasty for acute myocardial infarction (2003) (0)
- Latters to the editor (1988) (0)
- TCT-470 Two Year Clinical Results after Deployment of the Abluminal Sirolimus Coated Bio-Engineered (COMBO) Stent in a Thousand Patient All-Comers Registry. (2016) (0)
- ELEVATED BASELINE MYOGLOBIN FOR PREDICTION OF OCCLUDED INFARCT RELATED VESSEL IN NON-STEMI PATIENTS (2012) (0)
- chieved Platelet Aggregation Inhibition fter Different Antiplatelet Regimens uring Percutaneous Coronary Intervention or ST-Segment Elevation Myocardial Infarction (2016) (0)
- TCT-257: Long-Term Follow-up of the Platinum Chromium TAXUS Element (ION) Stent: PERSEUS Two-Year Results (2016) (0)
- 711-1 Angiopeptin Significantly Improves Twelve Months Event Free Survival Following PTCA in a Randomized Double Blind Study (1995) (0)
- Primary angioplasty vs. thrombolysis. (2007) (0)
- Abciximab in the Treatment of ST-Segment Elevation Myocardial Infarction—Reply (2005) (0)
- Safet and Efficacy of Recombinant Hirudin (CGP 39 393) Versus Heparin in Patients With Stable Angina Undergoing Coronary Angioplast (1993) (0)
- 1154-86 Hyperglycaemia reduces myocardial reperfusion during primary percutaneous coronary intervention for ST-elevation myocardial infarction (2004) (0)
- Prediction of success and major complications during elective coronary angioplasty. (2001) (0)
- 1081-57 Randomized comparison between stent and balloon in diabetic with ST-segment elevation myocardial infarction undergoing primary angioplasty: A substudy of the Zwolle-6 randomized trial (2004) (0)
- The effect of low birth weight on endothelial dysfunction in young adults: a retrospective cohort study (2014) (0)
- Hyperglycaemia reduces myocardial reperfusion after primary percutaneous coronary intervention for ST-elevation myocardial infarction (2004) (0)
- THE IMPORTANCE OF PRE-HOSPITAL INFARCT DIAGNOSIS AND THERAPY ON INITIAL PATENCY OF THE INFARCT RELATED VESSEL BEFORE PCI IN PATIENTS WITH STEMI (2010) (0)
- THE LEFT SUBCLAVIAN ARTERY AS PRIMARY ACCESS SITE FOR TRANSCATHETER AORTIC VALVE IMPLANTATION (2013) (0)
- 1217: Feasibility of Including Patients with Acute MI in A Randomised Controlled trial by Ambulance Nurses Only: Preliminary Results of the Ongoing Tirofiban in Myocardial Infarction Evaluation (On-Time) Study (2003) (0)
- and outcome? Does angiography six months after coronary intervention influence management (2011) (0)
- P5100The left subclavian artery as primary access site in TAVI; feasibility and outcomes (2018) (0)
- Application of quantitative coronary angiography in the study of pharmacologically induced coronary vasomotion (1994) (0)
- Stenting in acute MI: The Netherlands experience (1997) (0)
- Chapter 7 PCI techniques (2010) (0)
- AS-28: Patients Aged over 70 and 80 years in the Worldwide e-HEALING Registry: A High Risk Population with Favorable Outcome after Genous Stent Implantation (2010) (0)
- IMPACT OF AGEING ON THE FUNCTIONAL EVALUATION OF INTERMEDIATE CORONARY STENOSES WITH ADENOSINE-BASED FRACTIONAL FLOW RESERVE (FFR) AND INSTANTANEOUS WAVE-FREE RATIO (IFR) (2020) (0)
- Short‐term dual antiplatelet therapy in diabetic patients admitted for acute coronary syndrome treated with a new‐generation drug‐eluting stent (2022) (0)
- Impact of renal failure and high-platelet reactivity on major cardiovascular ischemic events among patients with acute coronary syndrome receiving dual antiplatelet therapy with ticagrelor. (2022) (0)
- PCI OutcomesTCT-492 Clinical Outcomes of a Fractional Flow Reserve-Guided Revascularization Strategy in Patients With Diabetes Mellitus. Results from a Single Center Registry (2015) (0)
- Chapter 4 Troponin T elevation and prognosis after multivessel compared to single vessel elective percutaneous coronary intervention (2008) (0)
- AS-88: Primary Coronary Intervention for ST-Segment Elevation Myocardial Infarction in Indonesia: Comparison with Europe (2009) (0)
- TCT-68 One Year Clinical Outcomes in Patients with Insulin-Treated Diabetes Mellitus and Non-Insulin-Treated Diabetes Mellitus Compared to Non-Diabetics after Deployment of the Abluminal Sirolimus Coated Bio-Engineered (COMBO) Stent in an All-Comers Registry. (2016) (0)
- DO STEMI PATIENTS WHO LIVE FURTHER AWAY FROM THE PCI CENTRE HAVE WORSE OUTCOME (2011) (0)
- Long term outcome and coste V ectiveness of stenting versus balloon angioplasty for acute myocardial infarction (2001) (0)
- Comprar Catheterization and Interventional Cardiology in Adult Patients | Petr Widimsky | 9780199558872 | Oxford University Press (2010) (0)
This paper list is powered by the following services:
